Navigation Links
Cellumen Establishes Collaboration in Breast Cancer Patient Stratification
Date:10/1/2007

PITTSBURGH, Oct. 1 /PRNewswire/ -- Cellumen, Inc. and Mayo Foundation for Medical Education and Research announced today the formation of a collaboration to apply cellular systems biology (CSB(TM)) profiling to breast cancer patient stratification. The goal is to create a breast cancer patient profile test to improve diagnosis and treatment for individualized medicine.

"We are very pleased to initiate an exciting research and development program with Mayo, a leader in individualized medicine," stated D. Lansing Taylor, Ph.D., CEO of Cellumen. "We are treating breast tumors as a 'system' within the breast cancer patient. A combination of breast cancer biomarkers and migratory immune cell biomarkers are being multiplexed in tissue micro-array (TMA) samples.

"We are enthusiastic about the synergy between Cellumen and Mayo in approaching this challenging opportunity," stated Taylor, "Mayo has great expertise and experience that will be applied to this collaboration. Cellumen continues to develop collaborations with the best in class partners to bring CSB solutions to the market."

About Cellumen

Cellumen, Inc. is the Cellular Systems Biology Company. Cellumen focuses on the cell as an integrated and interacting network of genes, proteins and metabolites responsible for normal and abnormal (disease) function. To promote efficient drug discovery and development, the company offers solutions to the dual challenges of efficacy and toxicity. The company's products and services have application in each of the major segments of the pharmaceutical pipeline: drug discovery ("cellular models of disease"), drug development ("cytotoxicity profiling") and clinical trials ("patient sample profiling"). The Cellumen team leverages its experience and expertise in High Content Screening, cell- based assays, advanced reagents and bioinformatics to create high value solutions. http://www.cellumen.com.


'/>"/>
SOURCE Cellumen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Strandware Founder Establishes Consulting Firm
2. RedPrairie Establishes Asia-Pacific Headquarters in Shanghai
3. West Coast VC Establishes Midwest Presence in Madison
4. Regional collaboration is key to states future
5. Cieslewicz, Barrett talk economic collaboration
6. Congress passes bill to ease researchers collaboration worries
7. Economic collaboration in Denver sets tall goal for Wisconsin
8. Better collaboration urged to further Wisconsin biotech
9. Southeastern Wisconsin Technology Collaboration
10. Big collaboration links learners to science on a tiny scale
11. UW-Madison releases open 3D collaboration environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... FireflySci Inc. ... exponential rate. The tremendous growth is accounted to two main factors. The ... and the expanding network of vendors supplying FireflySci products all around the world. , ...
(Date:1/19/2017)... , Jan. 18, 2017 Acupath Laboratories, ... announces the formation of an Executive Committee that will ... beyond. John Cucci , a 15-year ... from Director of Business Development to Chief Sales ... Mr. Cucci served in senior sales leadership roles at ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical , ... designed to target cancer stemness pathways, will feature data ... napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, held ... . Napabucasin is an orally-administered investigational ... STAT3. i Cancer stem cells (CSCs) possess the ...
(Date:1/18/2017)... ... 2017 , ... Total Orthopedics and Sports Medicine ( http://www.totalorthosportsmed.com ... operation took place on Wednesday, January 11, 2017 at Long Island Jewish, Valley ... discectomy and fusion on a 42 year old female who was in a ...
Breaking Biology Technology:
(Date:12/22/2016)... , December 22, 2016 SuperCom ... of secure solutions for the e-Government, Public Safety, HealthCare, and Finance ... of SuperCom, has been selected to implement and deploy a community-based ... Northern California , further expanding its presence in ... This ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical device ... billion by 2021 from USD 5.31 billion in 2016, at a ... ... driven by technological advancements in medical devices, launch of a growing ... for wireless connectivity among healthcare providers, and increasing focus on physical ...
Breaking Biology News(10 mins):